INSP Stock Recent News

INSP LATEST HEADLINES

INSP Stock News Image - Zacks Investment Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Investment Research 2024 Apr 18
INSP Stock News Image - Zacks Investment Research

Inspire (INSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks Investment Research 2024 Apr 18
INSP Stock News Image - Zacks Investment Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Investment Research 2024 Mar 18
INSP Stock News Image - Zacks Investment Research

The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research 2024 Feb 06
INSP Stock News Image - Zacks Investment Research

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.10 per share a year ago.

Zacks Investment Research 2024 Feb 06
INSP Stock News Image - Seeking Alpha

Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript

Seeking Alpha 2024 Feb 06
INSP Stock News Image - Zacks Investment Research

Inspire Medical's (INSP) revenue growth in the fourth quarter is likely to have been boosted by improved operating leverage.

Zacks Investment Research 2024 Jan 09
INSP Stock News Image - Zacks Investment Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Investment Research 2023 Dec 29
INSP Stock News Image - Zacks Investment Research

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research 2023 Dec 07
INSP Stock News Image - Zacks Investment Research

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Zacks Investment Research 2023 Nov 30
10 of 50